E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -9.14M -15.00M -28.74M -26.86M -26.34M
Total Depreciation and Amortization 243.00K 243.00K 243.00K 242.00K 242.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.64M 2.27M 2.94M 3.10M 2.48M
Change in Net Operating Assets -7.40M -13.52M 2.53M 1.19M -2.19M
Cash from Operations -14.67M -26.01M -23.02M -22.33M -25.80M
Capital Expenditure -- 0.00 0.00 -28.00K -5.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -7.35M -2.81M 18.04M 26.59M 13.05M
Cash from Investing -7.35M -2.81M 18.04M 26.56M 13.04M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 34.00K 12.00K 148.00K --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- 34.00K 12.00K 148.00K --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -22.02M -28.79M -4.97M 4.38M -12.76M